Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore

Journal of Medical Virology

Volumn 70, Issue 2, 2003, Pages 287-292

  Lim, C S ^a   Chan, K P ^b   Goh, K T ^c   Chow, Vincent T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NATIONAL ENVIRONMENT AGENCY   (Singapore)

Author keywords

HN gene; Mumps virus; Phylogeny; Rubini vaccine failure; Singapore

Indexed keywords

HN PROTEIN; MUMPS VACCINE; RUBINI VACCINE; UNCLASSIFIED DRUG;

ADAPTATION; ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGENICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EVOLUTION; FEMALE; GENETIC VARIABILITY; HUMAN; IMMUNIZATION; MALE; MUMPS; MUMPS VIRUS; MUMPS VIRUS JERYL LYNN STRAIN; MUMPS VIRUS RUBINI STRAIN; MUMPS VIRUS URABE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; SINGAPORE; TREATMENT FAILURE; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; HN PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; MUMPS; MUMPS VACCINE; MUMPS VIRUS; PAROTITIS; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SINGAPORE; TREATMENT FAILURE; VACCINATION;

MUMPS VIRUS;

EID: 0242416921     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10393     Document Type: Article

References (30)

1. Afzal MA, Pickford AR, Forsey T, Heath AB, Minor PD. 1993. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol 74:917-920.
2. Afzal MA, Buchanan J, Dias JA, Cordeiro M, Bentley ML, Shorrock CA, Minor PD. 1997. RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal. J Med Virol 52:349-353.
3. Afzal MA, Yates PJ, Minor PD. 1998. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis 177:265-266.
4. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. 1994. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 169:77-82.
5. Brown EG, Wright KE. 1998. Genetic studies on a mumps vaccine strain associated with meningitis. Rev Med Virol 8:129-142.
6. Brown EG, Dimock K, Wright KE. 1996. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis 174:619-622.
7. Chamot E, Toscani L, Egger P, Germann D, Bourquin C. 1998. Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland). Rev Epidemiol Sante Pub 46:100-107.
8. Cheek JE, Baron R, Atlas H, Wilson DL, Crider RD. 1995. Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med 149:774-778.
9. Chow VTK, Leong PWF. 1999. Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S. J Gen Virol 80:2923-2929.
10. Chungue E, Roche C, Lefevre MF, Barbazan P, Chanteau S. 1993. Ultra-rapid, simple, sensitive, and economical silica method for extraction of dengue viral RNA from clinical specimens and mosquitoes by reverse transcriptase-polymerase chain reaction. J Med Virol 40:142-145.
11. Committee on Epidemic Diseases. 2000. Efficacy of mumps virus vaccine. Epidemiol News Bull 26:45-47.
12. Crennell S, Takimoto T, Portner A, Taylor G. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 11:1068-1074.
13. Cusi MG, Correale P, Valassina M, Sabatino M, Valensin PE, Donati M, Gluck R. 2001. Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. Arch Virol 146:1241-1248.
14. Forsey T, Mawn JA, Yates PJ, Bentley ML, Minor PD. 1990. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. J Gen Virol 71:987-990.
15. Germann D, Strohle A, Eggenberger K, Steiner CA, Matter L. 1996. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 28:235-238.
16. Goh KT. 1999. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain. Lancet 354:1355-1356.
17. Gray JA, Burns SM. 1989. Mumps meningitis following measles, mumps, and rubella immunization. Lancet 2:98.
18. Jorgensen ED, Collins PL, Lomedico PT. 1987. Cloning and nucleotide sequence of Newcastle disease virus hemagglutinin-neuraminidase mRNA: identification of a putative sialic acid binding site. Virology 156:12-24.
19. Kovamees J, Rydbeck R, Orvell C, Norrby E. 1990. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 17:119-129.
20. Mirza AM, Deng R, Iorio RM. 1994. Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidase glycoprotein: effects on antigenic structure and function. J Virol 68:5093-5099.
21. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M, Kikuta H, Togashi T. 1998. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol 5:799-803.
22. Orvell C. 1984. The reactions of monoclonal antibodies with structural proteins of mumps virus. J Immunol 132:2622-2629.
23. Orvell C, Alsheikhly AR, Kalantari M, Johansson B. 1997. Characterization of genotype-specific epitopes of the HN protein of mumps virus. J Gen Virol 78:3187-3193.
24. Orvell C, Tecle T, Johansson B, Saito H, Samuelson A. 2002. Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 83:2489-2496.
25. Schulze IT. 1997. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis 176(suppl 1):S24-S28.
26. Schwarzer S, Reibel S, Lang AB, Struck MM, Finkel B, Gerike E, Tischer A, Gassner M, Gluck R, Stuck B, Cryz SJ. 1998. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. Vaccine 16:298-304.
27. Tecle T, Bottiger B, Orvell C, Johansson B. 2001. Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J Gen Virol 82:2675-2680.
28. Tecle T, Mickiene A, Johansson B, Lindquist L, Orvell C. 2002. Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch Virol 147:243-253.
29. Wandel G. 1999. Mumps component in combined measles, mumps, and rubella vaccines. Vaccine 17:511.
30. Yates PJ, Afzal MA, Minor PD. 1996. Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 77:2491-2497.